Holen Sie sich die Stockscreener-App
47.49
7.37%
3.25
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Costs And Expenses |
1.22%
27.72
|
27.38 | 27.43 | 25.95 | 24.94 |
| Operating Income/Loss |
1.22%
-27.72
|
-27.38 | -27.43 | -25.95 | -24.94 |
| Nonoperating Income/Loss |
6.77%
3.127
|
3.354 | 3.607 | 4.19 | 3.056 |
| Income/Loss From Continuing Operations Before Tax |
2.33%
-24.59
|
-24.03 | -23.82 | -21.76 | -21.88 |
| Income Tax Expense/Benefit |
28.12%
0.046
|
0.064 | 0.088 | 0.04 | 0.062 |
| Income/Loss From Continuing Operations After Tax |
2.25%
-24.64
|
-24.09 | -23.91 | -21.80 | -21.95 |
Net Income/Loss
|
2.25%
-24.64
|
-24.09 | -23.91 | -21.80 | -21.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.14%
91.70
|
91.58 | 91.47 | 3.9396 | 77.82 |
| Diluted Average Shares |
0.14%
91.70
|
91.58 | 91.47 | 3.9396 | 77.82 |
| Basic Earnings Per Share |
3.85%
-0.27
|
-0.26 | -0.26 | -0.23 | -0.28 |
| Diluted Earnings Per Share |
3.85%
-0.27
|
-0.26 | -0.26 | -0.23 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):